Article
LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions.
Molecular and cellular biochemistry - 1 Sept 2024
Lubrano Valter, Balzan Silvana, Papa Angela
Abstract excerpt
Atherosclerosis is one of the major causes of cerebral infarction and many other ischemic cardio-cerebrovascular diseases. Although large randomized clinical trials have highlighted the impressive benefits of lipid-lowering therapies, the 50-70% of patients who have achieved their lipid-lowering goal remain at high cardiovascular disease risk. For this reason, there is a need to investigate other markers of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
